ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)
Japan
· Delayed Price · Currency is JPY 2,256.00
+6.00 (0.27%)
Mar 10, 2026, 12:45 PM JST
TYO:4886 Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | 6,192 | 9,862 | 5,357 | 6,163 | 3,575 | Upgrade
|
| Depreciation & Amortization | - | 2,247 | 2,662 | 3,127 | 2,885 | 3,305 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 300 | 2 | 6 | -3,466 | 7 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -127 | -3,340 | -124 | 1,151 | -491 | Upgrade
|
| Loss (Gain) on Equity Investments | - | 53 | 41 | 19 | -18 | - | Upgrade
|
| Other Operating Activities | - | -3,938 | -1,532 | -854 | -2,224 | -226 | Upgrade
|
| Change in Accounts Receivable | - | 1,203 | -370 | -742 | -1,361 | 639 | Upgrade
|
| Change in Inventory | - | -2,675 | -2,713 | -2,627 | -687 | -330 | Upgrade
|
| Change in Accounts Payable | - | 339 | 1,494 | -980 | 412 | 392 | Upgrade
|
| Change in Other Net Operating Assets | - | -1,109 | -4,620 | 169 | -13 | -330 | Upgrade
|
| Operating Cash Flow | - | 2,485 | 1,486 | 3,351 | 2,842 | 6,541 | Upgrade
|
| Operating Cash Flow Growth | - | 67.23% | -55.66% | 17.91% | -56.55% | - | Upgrade
|
| Capital Expenditures | - | -2,960 | -1,320 | -461 | -579 | -1,104 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 1 | - | 10,312 | - | Upgrade
|
| Cash Acquisitions | - | -2,189 | -1,464 | - | -53 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -602 | -133 | -285 | -1,798 | - | Upgrade
|
| Investment in Securities | - | 752 | 3,778 | -210 | -45 | -1,743 | Upgrade
|
| Other Investing Activities | - | -1,125 | 844 | -170 | -1,094 | -19 | Upgrade
|
| Investing Cash Flow | - | -6,124 | 1,706 | -1,126 | 6,743 | -2,866 | Upgrade
|
| Long-Term Debt Issued | - | 3,000 | - | - | - | 77 | Upgrade
|
| Total Debt Issued | - | 3,000 | - | - | - | 77 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -50 | -100 | Upgrade
|
| Long-Term Debt Repaid | - | -4,680 | -3,138 | -1,423 | -2,298 | - | Upgrade
|
| Total Debt Repaid | - | -4,680 | -3,138 | -1,423 | -2,348 | -100 | Upgrade
|
| Net Debt Issued (Repaid) | - | -1,680 | -3,138 | -1,423 | -2,348 | -23 | Upgrade
|
| Repurchase of Common Stock | - | - | 9 | 55 | -248 | 52 | Upgrade
|
| Common Dividends Paid | - | -1,275 | -792 | -452 | -398 | -484 | Upgrade
|
| Other Financing Activities | - | -1 | -22 | - | -2 | - | Upgrade
|
| Financing Cash Flow | - | -2,956 | -3,943 | -1,820 | -2,996 | -455 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -97 | -15 | -2 | - | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 556 | - | -1 | - | -1 | Upgrade
|
| Net Cash Flow | - | -6,136 | -766 | 402 | 6,589 | 3,219 | Upgrade
|
| Free Cash Flow | - | -475 | 166 | 2,890 | 2,263 | 5,437 | Upgrade
|
| Free Cash Flow Growth | - | - | -94.26% | 27.71% | -58.38% | - | Upgrade
|
| Free Cash Flow Margin | - | -0.74% | 0.26% | 4.78% | 4.00% | 9.85% | Upgrade
|
| Free Cash Flow Per Share | - | -16.76 | 5.86 | 102.34 | 79.77 | 191.76 | Upgrade
|
| Cash Interest Paid | - | 51 | 41 | 51 | 58 | 58 | Upgrade
|
| Cash Income Tax Paid | - | 4,026 | 1,611 | 850 | 1,385 | 225 | Upgrade
|
| Levered Free Cash Flow | - | -6,568 | 6,972 | 2,067 | 633.5 | 4,744 | Upgrade
|
| Unlevered Free Cash Flow | - | -6,536 | 6,997 | 2,098 | 668.5 | 4,781 | Upgrade
|
| Change in Working Capital | - | -2,242 | -6,209 | -4,180 | -1,649 | 371 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.